61 related articles for article (PubMed ID: 38397877)
1. A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen.
Karmali R; Galvez C; Hamadani M; Gordon L; Winter J; Ma S; Nelson V; Fenske TS; Shah NN; Jagadeesh D; Klein A; Helenowski I; Chen R; Mi X; Petrich A; Evens AM; Pro B
Blood Adv; 2024 Apr; 8(7):1612-1620. PubMed ID: 38237077
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous presentation of Double Hit Lymphoma: A Case Report With Review of the Literature.
Khelfa Y; Lebowicz Y
J Investig Med High Impact Case Rep; 2016; 4(2):2324709616642592. PubMed ID: 27115017
[TBL] [Abstract][Full Text] [Related]
3. Current challenges and novel treatment strategies in double hit lymphomas.
Anderson MA; Tsui A; Wall M; Huang DC; Roberts AW
Ther Adv Hematol; 2016 Feb; 7(1):52-64. PubMed ID: 26834954
[TBL] [Abstract][Full Text] [Related]
4. Navigating Lymphomas through BCR Signaling and Double-Hit Insights: Overview.
Argentiero A; Andriano A; Marziliano D; Desantis V
Hematol Rep; 2024 Mar; 16(1):164-178. PubMed ID: 38534887
[TBL] [Abstract][Full Text] [Related]
5. EBER-Negative, Double-Hit High-Grade B-Cell Lymphoma Responding to Methotrexate Discontinuation.
Nai N; Coffman BB; Reiter K; Atweh G; Vashistha V
Fed Pract; 2024 May; 41(Suppl 2):S9-S13. PubMed ID: 38813249
[TBL] [Abstract][Full Text] [Related]
6. De Novo CD5-Positive Primary Gastric Diffuse Large B-Cell Lymphoma Coexpressing MYC and BCL6: Towards a Proper Subset of Double-Hit, Triple-Hit and, Maybe, Quadruple-Hit B-Cell Lymphomas?
Roncati L
Chonnam Med J; 2018 Jan; 54(1):80-82. PubMed ID: 29399573
[No Abstract] [Full Text] [Related]
7. Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.
Swerdlow SH
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):90-9. PubMed ID: 25696840
[TBL] [Abstract][Full Text] [Related]
8. [MYC-associated B-cell lymphomas: pathophysiology and treatment].
Nitta H
Rinsho Ketsueki; 2019; 60(3):155-164. PubMed ID: 31068510
[TBL] [Abstract][Full Text] [Related]
9. Do Double-Expressor High-Grade B-Cell Lymphomas Really Need Intensified Treatment? A Report from the Real-Life Series of High-Grade B-Cell Lymphomas Treated with Different Therapeutic Protocols at the Institute of Oncology Ljubljana.
Boltežar L; Rožman S; Gašljević G; Grčar Kuzmanov B; Jezeršek Novaković B
Biomedicines; 2024 Jan; 12(2):. PubMed ID: 38397877
[TBL] [Abstract][Full Text] [Related]
10. Double-hit and double-expressor primary central nervous system lymphoma: Experience from North India of an infrequent but aggressive variant.
Parkhi M; Chatterjee D; Radotra BD; Bal A; Yadav BS; Tripathi M
Surg Neurol Int; 2023; 14():172. PubMed ID: 37292392
[TBL] [Abstract][Full Text] [Related]
11. EBV
Liu H; Xu-Monette ZY; Tang G; Wang W; Kim Y; Yuan J; Li Y; Chen W; Li Y; Fedoriw GY; Zhu F; Fang X; Luedke C; Medeiros LJ; Young KH; Hu S
Histopathology; 2022 Feb; 80(3):575-588. PubMed ID: 34637146
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of 'double-hit' and 'double-expression' lymphomas.
Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X
J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma.
Huang S; Nong L; Wang W; Liang L; Zheng Y; Liu J; Li D; Li X; Zhang B; Li T
Diagn Pathol; 2019 Jul; 14(1):81. PubMed ID: 31315646
[TBL] [Abstract][Full Text] [Related]
14. Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome.
Dodero A; Guidetti A; Marino F; Tucci A; Barretta F; Re A; Balzarotti M; Carniti C; Monfrini C; Chiappella A; Cabras A; Facchetti F; Pennisi M; Rahal D; Monti V; Devizzi L; Miceli R; Cocito F; Farina L; Ricci F; Rossi G; Carlo-Stella C; Corradini P
Haematologica; 2022 May; 107(5):1153-1162. PubMed ID: 34289655
[TBL] [Abstract][Full Text] [Related]
15. Modern, real-world patterns of care and clinical outcomes among patients with newly diagnosed diffuse large B-cell lymphoma with or without double/triple-hit status in the United States.
Goyal G; Magnusson T; Wang X; Roose J; Narkhede M; Seymour E
Haematologica; 2023 Apr; 108(4):1190-1195. PubMed ID: 36453108
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
